key: cord-0797456-5gfsn8b8 authors: Chen, Chih-Hao; Liu, Chi-Hung; Chi, Nai-Fang; Sung, Pi-Shan; Hsieh, Cheng-Yang; Lee, Meng; Tang, Sung-Chun; Jeng, Jiann-Shing title: Maintenance of Stroke Care Quality amid the Coronavirus Disease 2019 Outbreak in Taiwan date: 2020-09-29 journal: J Stroke DOI: 10.5853/jos.2020.02292 sha: 922ade944ee33d41f77870792b489db1b7d6f065 doc_id: 797456 cord_uid: 5gfsn8b8 nan It is well known that the implementation of evidence-based stroke care guidelines can effectively improve outcomes and prevent recurrence in patients with stroke. 1 In 2010, Taiwan implemented a nationwide collaborative model called the Breakthrough Series (BTS)-Stroke activity, adapted from the Get With The Guideline-Stroke program; this significantly improved outcomes on quality measures of acute ischemic stroke (AIS) care. 2 During the coronavirus disease 2019 (COVID-19) pandemic, routine care of stroke may be compromised because of realloca-tion of medical resources. In Taiwan, the first confirmed COV-ID-19 case was reported on January 21, 2020. Because of the Taiwanese government's aggressive containment efforts, 3 the cumulative number of COVID-19 cases, as of May 2020, was as low as 442. Whether the number of daily admissions and quality metrics for stroke care changed during the COVID-19 pandemic period warrants investigation. We retrospectively analyzed registry-based data from 18 hospitals in Taiwan, including seven medical centers and 11 community hospitals. The 18 hospitals were distributed in Taiwan's different administrative districts and contained >65% of the total Table 1 ). All the hospitals had participated in the BTS-Stroke activity. 2 The performance measures and safety indicators were modified from the original BTS-Stroke quality metrics established in 2010 (Supplementary Table 2 ) and were reviewed monthly. Individual patient-level information was de-identified before analysis. Number of monthly admissions of stroke (including ischemic and hemorrhagic stroke) and 15 quality-of-care metrics were compared between the main outbreak (March 2020), early outbreak (January and February 2020), and control (January to March 2019) phases, respectively. Since the BTS-Stroke activity mainly focused on the AIS-related quality metrics, number of AIS admission were further recorded. Detailed methods and statistical analyses are presented in the Supplementary methods. As the cumulative number of COVID-19 cases increased, there was a significant decrease in mean daily stroke admissions in the first quarter of 2020 (β=−0.07, P<0.001), which was not ob-served in 2019 (β=−0.03, P=0.13) ( Figure 1A ). Similar trends were observed in medical centers (β=−0.07, P=0.007) and community hospitals (β=−0.07, P=0.02) ( Figure 1B) . The comparison between the first quarter of 2019 and 2020 was presented in Table 1 . The number of daily stroke admission were decreased in 2020 compared with 2019 (41.2 vs. 44.3; incidence rate ratio [IRR], 0.93; P=0.001) as well as AIS admission (29.9 vs. 32.6; IRR, 0.93; P=0.001). The quality metrics were generally comparable, and several metrics of intravenous thrombolysis, endovascular thrombectomy, early and discharge antithrombotic use, and rehabilitation evaluation even improved in 2020. P=0.001) increased in the main outbreak phase. The quality metrics of rehabilitation evaluation and stroke education also improved. We found that most stroke quality measures during the current study periods considerably improved compared to the initial BTS-Stroke activity implementation period of 2010 to 2011. 2 More importantly, the overall quality of acute stroke care was well-maintained or even further improved for several metrics during the early and main outbreak periods, indicating that the effect of the quality improvement program persists over time. As expected, stroke admissions in Taiwan decreased by approximately 13% to 16% in the main COVID-19 outbreak phase in the main COVID-19 outbreak phase. However, the reduction appears much less than the global average of 42% reduction reported by the World Stroke Organization. 4 During the outbreak, patients with mild stroke symptoms may be less willing or may took longer time to visit the hospital. 5 Our data showed a trend of decreasing proportion of mild stroke (National Institutes of Health Stroke Scale [NIHSS] <4; 40.2% vs. 42.6%; OR, 0.91; P=0.07) and mild to moderate stroke (NIHSS <10; 73.3% vs. 76.0%; OR, 0.87; P=0.02) in 2020 compared with 2019. Besides, the number of early arrivals was higher in 2020 than 2019; these patients most likely had considerable neurological signs and were thus sent to hospitals earlier. The proportion of patients receiving acute reperfusion therapy did not decrease in 2020, suggesting that the quality of acute intervention of stroke were still maintained during the pandemic. When encountering an outbreak of a highly contagious disease, the performance of timely and emergent acute stroke care could be compromised. Modification of the hyperacute stroke management protocol has been advocated during this pandemic in many countries, including Taiwan. 6, 7 In this study, the proportion of patients with a door-to-computed tomography time ≤25 minutes was lower in the main outbreak phase, which would have resulted in delaying hyperacute stroke management. 8 Nevertheless, the proportion of patients with a door-to-needle time ≤60 minutes in our study was not affected, suggesting that the participating hospitals made their best effort to adhere to hyperacute stroke protocols. The main limitation of our study was that we were able to use month-based hospital-level data only, and detailed individual patient-level data such as demographic profiles and stroke severities could not be analyzed. In addition, Taiwan was far less severely affected by the pandemic compared with other countries, hence the generalizability of our results should be taken into consideration. In conclusion, we showed that the collateral adverse effect on stroke admission even in a country less affected by COVID-19. Well-implemented performance improvement program could lead to a fair maintenance of stroke care quality even during the public health crises. The data covered 18 hospitals in Taiwan's different administrative districts; these districts together contain >65% of the total population. The enrolled hospitals included seven medical centers and 11 community hospitals, and the corresponding principal investigators were all members of Taiwan Stroke Society (Supplementary Table 1 ) and participants of the BTS-Stroke activity, where they received training in the measurement of quality and safety from trained neurologists, study nurses, and stroke case managers. The details of the training and data collection process involved in the BTS-Stroke activity has been reported previously. 6 Individual patient-level information was de-identified before analysis. This study was approved by the National Taiwan University Hospital Research Ethics Committee, No. 202004035RINA. The original BTS-Stroke quality metrics were established in 2010. It included 14 performance measures and safety indicators. These indicators are the percentage of (1) patients presenting with stroke symptoms for <2 hours who have a door-to-computed tomography time ≤25 minutes; (2) patients who arrived at the participating hospital <2 hours after symptom onset who use an intravenous tissue plasminogen activator (IV-tPA; IV-tPA for early arrival); (3) patients with acute ischemic stroke (AIS) who receive IV-tPA treatment; (4) patients who arrived <2 hours after symptom onset who have a of door-to-needle time ≤60 minutes; (5) patients who underwent IV-tPA treatment who developed symptomatic intracerebral hemorrhage (ICH); (6) patients with AIS who receive intraarterial thrombolysis; (7) patients who use antithrombotic medication use ≤48 hours upon admission (early antithrombotic use); (8) patients who undergo dysphagia screening before any oral intake; (9) patients with atrial fibrillation who are prescribed oral anticoagulants at discharge; (10) patients with a lipid-lowering drug prescription for low-density lipoprotein ≥100 mg/dL at discharge (lipid-lowering drug use); (11) patients with an antithrombotic prescription at discharge (antithrombotic use at discharge); (12) patients who are evaluated for stroke rehabilitation services (rehabilitation evaluation); (13) patients (and/or caregivers) who undergo stroke education (stroke education); and (14) patients with stroke who have a 30-day mortality. Since 2015, endovascular thrombectomy (EVT) has become the standard treatment for patients with AIS with large vessel occlusion. Therefore, we replaced intraarterial thrombolysis with EVT and added metric 15: symptomatic ICH after EVT (Supplementary Table 2 ). Stroke severity, represent-ing by National Institutes of Health Stroke Scale (NIHSS), was not included in the BTS-Stroke activity. Nevertheless, we collected patients' NIHSS score according to four strata as <4, 4 to 10, 11 to 20, and >20. All quality metrics were reviewed on a monthly basis in each participating hospital. Furthermore, the total number of monthly stroke admissions (including those of AIS, transient ischemic attack and hemorrhagic stroke) were recorded. Since the BTS-Stroke activity mainly focused on the AIS-related quality metrics, we further recorded number of AIS admission. The study period was January 1 to March 31, 2020, and the control period was January 1 to March 31, 2019. Coronavirus disease 2019 (COVID-19) statistics were collected from the bulletins and press releases of the Central Epidemic Command Center (CECC), a specialized task force under Taiwan's Centers for Disease Control. We collected the daily numbers of confirmed cases (reported from home quarantine and enhanced surveillance). The mean daily stroke and AIS admissions were calculated from data on their monthly counterparts (monthly figures/number of days of the month). The changes over the 3 consecutive months were estimated using a generalized estimating equation. The difference in the mean values between different study periods were compared using Poisson regression and expressed as incidence rate ratios and their 95% confidence intervals. All quality metrics were represented as percentages (%). Because the denominator in these percentages may change according to which patients are covered by any given quality metrics, both the numerator and denominator are reported in the results. When appropriate, the chi-square test or Fisher's exact test was used to compare quality metrics between the study and control periods. Logistic regression analysis was used to calculate the odds ratios for quality of care between the 2 periods, and the penalized maximum likelihood (Firth method) was used for parameter estimation to determine the likelihood of rare outcomes. 7 In brief, we first compared the first quarters of 2019 and 2020 with respect to the mean numbers of daily stroke admission of stroke and the quality-metric percentages. Prespecified subgroup analyses were performed for medical centers and community hospitals. Because the number of confirmed COV-ID-19 cases increased substantially in mid-March, we considered March 2020 as the most affected month (i.e., the main outbreak phase). Thus, we further compared data for March Get With The Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack Quality improvement in acute ischemic stroke care in Taiwan: the breakthrough collaborative in stroke Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing The global impact of COVID-19 on acute stroke care Delays in stroke onset to hospital arrival time during COVID-19 Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic Management of hyperacute stroke during the coronavirus disease of 2019 pandemic: the modified code stroke in a medical center in Taiwan Mechanical thrombectomy for acute ischemic stroke amid the COVID-19 outbreak: decreased activity, and increased care delays the early outbreak phase) and the first quarter of 2019 (i.e., the control phase), respectively. All statistical analyses were performed using SAS version 9 Tzu Chi Hospital Community hospital New Taipei city Po-Jen Hsu, MD; Shinn-Kuang Lin, MD Cardinal Tien Hospital Community hospital New Taipei city Chung-Fen Tsai PhD Landseed International Hospital Community hospital Taoyuan city Supplementary materials related to this article can be found online at https://doi.org/10.5853/jos.2020.02292.